Literature DB >> 17291936

Roles of rho-associated kinase and oxidative stress in the pathogenesis of aortic stiffness.

Kensuke Noma1, Chikara Goto, Kenji Nishioka, Daisuke Jitsuiki, Takashi Umemura, Keiko Ueda, Masashi Kimura, Keigo Nakagawa, Tetsuya Oshima, Kazuaki Chayama, Masao Yoshizumi, James K Liao, Yukihito Higashi.   

Abstract

OBJECTIVES: The purpose of this study was to determine the relationship between Rho-associated kinase (ROCK) activity and aortic stiffness in humans.
BACKGROUND: Epidemiologic studies have shown that there is a relationship between aortic stiffness and cardiovascular complications. Recent evidence suggests that ROCK plays an important role in the process of atherosclerosis.
METHODS: We evaluated the forearm blood flow (FBF) response to sodium nitroprusside (SNP), a nitric oxide donor, acetylcholine (ACh), an endothelium-dependent vasodilator, and fasudil, a specific ROCK inhibitor, in 51 healthy male subjects (mean age 45.6 +/- 3.0 years). The FBF was measured by using a strain-gauge plethysmography. Carotid-femoral pulse wave velocity (cf-PWV) was measured to assess the aortic stiffness using a pulse wave velocimeter.
RESULTS: Intra-arterial infusion of SNP alone, ACh alone, or fasudil alone and after co-infusion of N(G)-monomethyl-L-arginine (L-NMMA), a nitric-oxide synthase inhibitor, significantly increased FBF in a dose-dependent manner (p < 0.01). Multivariate analysis showed that age and number of pack-years smoked were independent predictors of ROCK activity before or after co-infusion of L-NMMA (p < 0.01) and that age and ROCK activity before or after co-infusion of L-NMMA were independent predictors of cf-PWV (p < 0.01). The concentration of serum malondialdehyde-modified low-density lipoprotein, an index of oxidative stress, was significantly correlated with ROCK activity before and after co-infusion of L-NMMA and cf-PWV (p < 0.01).
CONCLUSIONS: These findings suggest that aging and accumulating smoking habit, which might induce excessive oxidative stress, are involved in ROCK activity in the vasculature, leading to an increase in aortic stiffness in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17291936      PMCID: PMC2615568          DOI: 10.1016/j.jacc.2006.06.082

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  39 in total

1.  Age-related RhoA expression in blood vessels of rats.

Authors:  L Miao; J W Calvert; J Tang; A D Parent; J H Zhang
Journal:  Mech Ageing Dev       Date:  2001-10       Impact factor: 5.432

2.  Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients.

Authors:  S Laurent; P Boutouyrie; R Asmar; I Gautier; B Laloux; L Guize; P Ducimetiere; A Benetos
Journal:  Hypertension       Date:  2001-05       Impact factor: 10.190

3.  Elevated RhoA/Rho-kinase activity in the aged rat penis: mechanism for age-associated erectile dysfunction.

Authors:  Liming Jin; Tongyun Liu; Gwen A Lagoda; Hunter C Champion; Trinity J Bivalacqua; Arthur L Burnett
Journal:  FASEB J       Date:  2006-01-05       Impact factor: 5.191

4.  Rho kinase inhibitor HA-1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cells.

Authors:  H Nagumo; Y Sasaki; Y Ono; H Okamoto; M Seto; Y Takuwa
Journal:  Am J Physiol Cell Physiol       Date:  2000-01       Impact factor: 4.249

5.  Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension.

Authors:  J J Mourad; B Pannier; J Blacher; A Rudnichi; A Benetos; G M London; M E Safar
Journal:  Kidney Int       Date:  2001-05       Impact factor: 10.612

6.  Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease.

Authors:  T Heitzer; T Schlinzig; K Krohn; T Meinertz; T Münzel
Journal:  Circulation       Date:  2001-11-27       Impact factor: 29.690

7.  Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries.

Authors:  N Sawada; H Itoh; K Ueyama; J Yamashita; K Doi; T H Chun; M Inoue; K Masatsugu; T Saito; Y Fukunaga; S Sakaguchi; H Arai; N Ohno; M Komeda; K Nakao
Journal:  Circulation       Date:  2000-05-02       Impact factor: 29.690

8.  Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension.

Authors:  M Uehata; T Ishizaki; H Satoh; T Ono; T Kawahara; T Morishita; H Tamakawa; K Yamagami; J Inui; M Maekawa; S Narumiya
Journal:  Nature       Date:  1997-10-30       Impact factor: 49.962

Review 9.  Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress.

Authors:  H Cai; D G Harrison
Journal:  Circ Res       Date:  2000-11-10       Impact factor: 17.367

10.  Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial.

Authors:  M Boaz; S Smetana; T Weinstein; Z Matas; U Gafter; A Iaina; A Knecht; Y Weissgarten; D Brunner; M Fainaru; M S Green
Journal:  Lancet       Date:  2000-10-07       Impact factor: 79.321

View more
  43 in total

Review 1.  The role of Rho protein signaling in hypertension.

Authors:  Gervaise Loirand; Pierre Pacaud
Journal:  Nat Rev Cardiol       Date:  2010-08-31       Impact factor: 32.419

2.  Measurement of Rho-associated kinase (ROCK) activity in humans: validity of leukocyte p-MBS/t-MBS in comparison with vascular response to fasudil.

Authors:  Takaki Hata; Chikara Goto; Junko Soga; Takayuki Hidaka; Yuichi Fujii; Naomi Idei; Noritaka Fujimura; Tatsuya Maruhashi; Shinsuke Mikami; Yasuki Kihara; Kazuaki Chayama; Kensuke Noma; James K Liao; Yukihito Higashi
Journal:  Atherosclerosis       Date:  2010-10-12       Impact factor: 5.162

Review 3.  Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.

Authors:  Chao-Yung Wang; Ping-Yen Liu; James K Liao
Journal:  Trends Mol Med       Date:  2008-01       Impact factor: 11.951

Review 4.  Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.

Authors:  Naoki Sawada; James K Liao
Journal:  Antioxid Redox Signal       Date:  2013-09-24       Impact factor: 8.401

Review 5.  Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.

Authors:  Jianjian Shi; Lei Wei
Journal:  J Cardiovasc Pharmacol       Date:  2013-10       Impact factor: 3.105

6.  A method for measuring Rho kinase activity in tissues and cells.

Authors:  Ping-Yen Liu; James K Liao
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

7.  Rho-associated kinase activity, endothelial function, and cardiovascular risk factors.

Authors:  Junko Soga; Kensuke Noma; Takaki Hata; Takayuki Hidaka; Yuichi Fujii; Naomi Idei; Noritaka Fujimura; Shinsuke Mikami; Tatsuya Maruhashi; Yasuki Kihara; Kazuaki Chayama; Hitoshi Kato; James K Liao; Yukihito Higashi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07-07       Impact factor: 8.311

8.  Two functional polymorphisms of ROCK2 enhance arterial stiffening through inhibiting its activity and expression.

Authors:  Yi-Chu Liao; Ping-Yen Liu; Hsiu-Fen Lin; Wen-Yi Lin; James K Liao; Suh-Hang H Juo
Journal:  J Mol Cell Cardiol       Date:  2014-12-03       Impact factor: 5.000

9.  Low total antioxidative capacity levels are associated with augmentation index but not pulse-wave velocity.

Authors:  Omer Gedikli; Serkan Ozturk; Hulya Yilmaz; Merih Baykan; Abdulkadir Kiris; Ismet Durmus; Kayhan Karaman; Caner Karahan; Sukru Celik
Journal:  Heart Vessels       Date:  2009-09-27       Impact factor: 2.037

Review 10.  Applications for ROCK kinase inhibition.

Authors:  Michael F Olson
Journal:  Curr Opin Cell Biol       Date:  2008-02-20       Impact factor: 8.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.